ACXP · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2024-08-08 compared with 2024-05-14 · 3 added, 1 removed, 25 unchanged (14% of the section changed)
OTHER INFORMATION
−Removed: None of our directors or officers have ado pted , modified, or termi nated any trading plans under Rule 10b5-1 of the Exchange Act or any similar arrangements during the three months ended March 31, 2024.
+Added: None of our directors or officers have ado pted , modified, or termi nated any trading plans under Rule 10b5-1 of the Exchange Act or any similar arrangements during the six months ended June 30, 2024.
The exhibits listed in the accompanying index to exhibits are filed or incorporated by reference as part of this Quarterly Report.
17 unchanged sentences
Acurx Pharmaceuticals, Inc.
+Added: August 8, 2024
President and Chief Executive Officer
(Principal Executive Officer)
+Added: August 8, 2024
/s/ Robert G.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.